84 filings
8-K
ADMS
Adamas Pharmaceuticals Inc
24 Nov 21
Completion of Acquisition or Disposition of Assets
9:18am
8-K
ADMS
Adamas Pharmaceuticals Inc
12 Oct 21
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
6:59am
8-K
ADMS
Adamas Pharmaceuticals Inc
9 Aug 21
Adamas reports second quarter 2021 financial results
4:04pm
8-K
ADMS
Adamas Pharmaceuticals Inc
11 Jun 21
Departure of Directors or Certain Officers
4:00pm
8-K
ADMS
Adamas Pharmaceuticals Inc
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
9c14 wwmui
10 May 21
Adamas reports first quarter 2021 financial results
4:04pm
8-K
8xu9lfm uy937
25 Feb 21
Other Events
4:15pm
8-K
lyj u1zq6s0wsyuz9adj
23 Feb 21
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
wkwg8ef6mjd5zm9 i22
1 Feb 21
Entry into a Material Definitive Agreement
8:05am
8-K
1jzg8 pdjm3zuqmg
13 Jan 21
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
9:27am
8-K
f0ot8
2 Dec 20
Entry into a Material Definitive Agreement
6:59am
8-K
o3v8fg1x
23 Nov 20
Departure of Directors or Certain Officers
9:20am
8-K
2ajmgcqr
5 Nov 20
Adamas Reports Third Quarter 2020 Financial Results
4:08pm
8-K
56x 6sgxt
1 Sep 20
Departure of Directors or Certain Officers
9:19am
8-K
1275nbz9pfsl71
6 Aug 20
Adamas Reports Second Quarter 2020 Financial Results
4:04pm
8-K
fmv1lm
17 Jun 20
Other Events
4:03pm
8-K
gtf3tt8ie7
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
bglc5svl 5urk76pnnv
4 Jun 20
Other Events
4:32pm
8-K
017xz5q8
7 May 20
Adamas Reports First Quarter 2020 Financial Results
4:07pm
8-K
c7qbs
25 Feb 20
Adamas Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm